wegovy weight loss pen/wegovy where to buy/wegovy side effects/wegovy weight loss reviews reddit/wegovy first month results forum/affordable Wegovy for sale/weight loss pills/Saxenda usa
1 Month packs can vary in price depending on the strength.
There are also multi-month bundles available for higher strengths, to lower your weekly cost. Some patients choose to maintain at 1mg from an affordability perspective, however maximum weight loss is achieved at the 2.4mg dose.
This is the starter dose
This is the dose which follows on from 0.25mg and continue to allow safe titration
You should start to notice significant weight loss from the 1mg dose
This dose should only be used after titration. Weight loss effects are more noticeable.
This is the highest strength of Wegovy, and the one that can help achieve most weight loss
Wegovy is a new weight-loss treatment, designed to make you feel less hungry. It is a once weekly injection under the skin (subcutaneous injection).
Wegovy contains the active ingredient semaglutide, and is prescribed for adults with obesity. It was approved in the USA in 2021, and was made available in the UK in September 2023.
If you find that Wegovy is not suitable for you, other weight loss treatments like such as Saxenda are currently available from our online doctor weight loss clinic.
Wegovy is a weight loss injection that can be an effective aid to weight-loss when used alongside a reduced-calorie diet and increased exercise. The weight loss drug contains the active ingredient semaglutide. Unlike other weight loss shots, Wegovy is injected once a week and can be used by adults with a body mass index (BMI) over 30. It can also be used by people with a BMI over 27 with weight-related conditions (such as high blood pressure or type 2 diabetes).
Wegovy (semaglutide) is approved in the USA, EU, UK, Japan, and Canada
| Saxenda | Wegovy | |
| Dose | One dose DAILY | One dose WEEKLY |
| Pens used per month | 5 | 1 |
| Shop with Bestmedstoreusa | Shop with Bestmedstoreusa | Shop with Bestmedstoreusa |
| Effectiveness | ~10% body weight loss | ~15% body weight loss |
Clinical trials have shown that Wegovy treatment resulted in a statistically significant reduction in body weight compared to placebo after 68 weeks. One trial showed that people taking Wegovy had a mean change in body weight of 14.9% compared to 2.4% in the placebo group.
The results also showed that, after 68 weeks, 83.5% of patients lost 5% or more of their body weight. In the placebo group, 31.1% of patients lost 5% or more of their body weight. Another clinical trial also showed a statistically significant reduction in body weight vs placebo.
The National Institute for Health and Care Excellence (NICE) has recommended Wegovy for weight management for those living with obesity due to the highly positive trial results.
| Dose | Inject ONCE weekly, following the dose-escalation schedule |
|---|---|
| Type of medicine | Appetite-suppressant – GLP-1 receptor agonist |
| Mechanism | Suppresses appetite and promotes feeling full for longer, decreasing food intake. |
| Active Ingredient | Semaglutide |
| Side Effects | Can include nausea, diarrhoea, constipation, abdominal pain, vomiting |
Reviews
There are no reviews yet.